NexPoint Event Driven Fund Class C · NASDAQ:HHCCX
NexPoint Event Driven Fund Class C — NexPoint Capital — Q1 2026 Earnings Presentation
11 slides from NexPoint Event Driven Fund Class C's earnings presentation, Jun 29, 2026
Slide 1: NexPoint Capital, Inc. Q1 2026 Investor Presentation
Q1 2026 INVESTOR PRESENTATION NexPoint Capital, Inc.
Slide 2: Snapshot
NEXPOINT CAPITAL, INC Snapshot Portfolio Characteristics1 NexPoint Capital, Inc. is a non-traded business development Number of Investments 21 company (“BDC”) that seeks to provide investors access to the unique opportunities offered by the historic changes to our Net Asset Value Per Share $4.34 nat
Slide 3: Holdings
NEXPOINT CAPITAL, INC Holdings1 Top Holdings Percentages Top Contributors Sapience 23.3% Position Asset Industry MidWave Wireless, Common Stock Telecom MidWave Wireless, Inc. 19.6% Inc. CCS Medical Inc. Bank Loan Healthcare US Gaming 9.6% iHeart CCS Medical 8.2% Media/ Communications Corporate Bonds
Slide 4: Key Investments
NEXPOINT CAPITAL, INC Key Investments INVESTMENT % PORTFOLIO THESIS KEY HIGHLIGHTS Sapience 23.3% Private company using Raised more than $100MM in outside proprietary technology to create capital while specializing in developing novel treatments for untreatable peptide-based therapeutics to treat ca
Slide 5: Key Holdings
NEXPOINT CAPITAL, INC Key Holdings 5
Slide 6: Sapience Therapeutics
TOP HOLDINGS DETAIL Sapience Therapeutics A privately held, clinical-stage biotechnology company focused on discovering and developing peptide therapeutics to address oncogenic and immune dysregulation that drive cancer INVESTMENT RATIONALE & OBJECTIVE • With two platforms that are purpose-built to
Slide 7: MidWave Wireless, Inc.
TOP HOLDINGS DETAIL MidWave Wireless, Inc. MidWave Wireless, Inc., is one of the largest independent wireless spectrum license holders in the U.S. INVESTMENT RATIONALE & OBJECTIVE • MidWave’s mid-band spectrum investments cover every major domestic market, representing more than 3.3 billion MHz-POPs
Slide 8: CCS Medical
TOP HOLDINGS DETAIL CCS Medical A leading national distributor of home medical equipment and supplies for patients with chronic conditions, with a focus on diabetes management INVESTMENT RATIONALE & OBJECTIVE • CCS is at the forefront of the rapidly growing distribution market for continuous glucose
Slide 9: PlantSwitch
TOP HOLDINGS DETAIL PlantSwitch PlantSwitch’s mission is to replace all petroleum-based single-use plastic with plants. Our proprietary technology upcycles agricultural residues into a plant-based resin that can be used to make nearly all types of plastic products. INVESTMENT RATIONALE & OBJECTIVE •
Slide 10: Disclosures
APPENDIX Disclosures NexPoint Capital, Inc. concluded the company’s public offering on February 14, 2018. For more information, please see the 8-K on the Fund website, www.nexpoint.com. Investing in our shares of common stock may be considered speculative and involves a high degree of risk, includin
Slide 11: Visit Our Website www.nexpoint.com
ADDRESS VISIT OUR 300 Crescent Court WEBSITE Suite 700 www.nexpoint.com Dallas, TX 75201 CONTACT SALES (833) 697-7253 NVESTOR SUPPORT IR@nexpoint.com